Amarin Corp. plc, which has research headquarters in Groton, reported a first-quarter loss of $88.3 million compared with an $18.3 million profit for the same period last year.
The loss was a little more than analysts expected.
But company president Joseph Zakrzewski pointed out that the quarter's milestones included the issuance of $150 million in exchangeable senior notes and approval of one of its major patent applications.
"The first quarter was very positive for Amarin," he said in a statement.
Zakrzewski said Amarin's lead drug candidate is on schedule for regulatory approval in July and launch in the first quarter of 2013.
Have you ever spotted any celebrities around the region? Tell us who, where and when via email to tips@theday.com. Include photos if possible.
What was your reaction to President Obama announcing his support for same-sex marriage?
|
||||||||||||||||||||
HIDE COMMENTS
HIDE COMMENTS